by October Gallery
BEIJING (Reuters) – Shanghai Junshi Biosciences has started an early-stage study in China to test a potential antibody treatment against the coronavirus in uninfected people, official paper Liberation Daily said…
ZURICH (Reuters) – Switzerland on Saturday reported 6,100 coronavirus infections, 25% more than a day earlier, and 56 deaths, the Swiss health ministry said, as the canton of Ticino that…
OTTAWA (Reuters) – Canadian Prime Minister Justin Trudeau and his wife Sophie are in self-isolation after she came down with flu-like symptoms and was tested for the new coronavirus, according…
FILE PHOTO: Canada’s Prime Minister Justin Trudeau and his wife Sophie Gregoire Trudeau hold white roses as they attend a vigil on top of Mount Royal marking the thirtieth anniversary…
(Reuters) – Biogen Inc said on Friday it would discontinue the development of its experimental therapy for a rare brain disease after the treatment failed a mid-stage trial, the latest…
(Reuters) – Shares of Sarepta Therapeutics Inc (SRPT.O) soared 36% on Friday after U.S. regulators shocked Wall Street by approving the company’s treatment for a muscle-wasting disorder less than four…
FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009. REUTERS/Jason Reed/File Photo (Reuters) – The U.S. Food and…
(Reuters) – Adamis Pharmaceuticals Corp (ADMP.O) said on Monday the U.S. Food and Drug Administration declined to approve its opioid overdose treatment, Zimhi, sending its shares plunging 56%. In a…
(Reuters) – CymaBay Therapeutics Inc said on Monday it was scrapping two mid-stage trials of its liver disease drug, after biopsies found a type of liver damage in some patients,…
(Reuters) – The U.S. Food and Drug Administration said on Monday it approved a drug from Global Blood Therapeutics Inc to treat sickle cell disease in adults and children 12…